nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.0092	0.099	CbGpPWpGaD
Fosaprepitant—TACR1—G alpha (q) signalling events—OPN4—glaucoma	0.00492	0.0529	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—C1QB—glaucoma	0.00478	0.0514	CbGpPWpGaD
Fosaprepitant—TACR1—G alpha (q) signalling events—PTGFR—glaucoma	0.00443	0.0477	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	0.0044	0.0473	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	0.00396	0.0426	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.0033	0.0355	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.00326	0.0351	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.00293	0.0316	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—NGFR—glaucoma	0.00253	0.0273	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—OPN4—glaucoma	0.00248	0.0267	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.00236	0.0254	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—PTGFR—glaucoma	0.00223	0.024	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—BDNF—glaucoma	0.0022	0.0237	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—IL1A—glaucoma	0.00212	0.0228	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—BDNF—glaucoma	0.00176	0.019	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—IL1A—glaucoma	0.00169	0.0182	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—NGF—glaucoma	0.00156	0.0168	CbGpPWpGaD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.00156	0.0168	CbGpPWpGaD
Fosaprepitant—TACR1—G alpha (q) signalling events—EDN1—glaucoma	0.00147	0.0158	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—EDN1—glaucoma	0.00145	0.0156	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—OPN4—glaucoma	0.0014	0.0151	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	0.00132	0.0142	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—OPN4—glaucoma	0.00127	0.0137	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—C3—glaucoma	0.00127	0.0137	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—PTGFR—glaucoma	0.00126	0.0136	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—PTGS2—glaucoma	0.00119	0.0128	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—PTGFR—glaucoma	0.00115	0.0123	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—SMO—glaucoma	0.00113	0.0121	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—CDKN1B—glaucoma	0.00112	0.0121	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—LRP12—glaucoma	0.00108	0.0117	CbGpPWpGaD
Fosaprepitant—TACR1—Spinal Cord Injury—MMP9—glaucoma	0.00104	0.0112	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000975	0.0105	CbGpPWpGaD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000852	0.00917	CbGpPWpGaD
Fosaprepitant—Eye disorder—Betaxolol—glaucoma	0.000816	0.0009	CcSEcCtD
Fosaprepitant—Pruritus—Apraclonidine—glaucoma	0.000815	0.000899	CcSEcCtD
Fosaprepitant—Body temperature increased—Acetazolamide—glaucoma	0.000815	0.000898	CcSEcCtD
Fosaprepitant—Fatigue—Dorzolamide—glaucoma	0.000815	0.000898	CcSEcCtD
Fosaprepitant—Tinnitus—Betaxolol—glaucoma	0.000815	0.000898	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Travoprost—glaucoma	0.000812	0.000895	CcSEcCtD
Fosaprepitant—Fatigue—Travoprost—glaucoma	0.000811	0.000894	CcSEcCtD
Fosaprepitant—Flushing—Betaxolol—glaucoma	0.000811	0.000894	CcSEcCtD
Fosaprepitant—Cardiac disorder—Betaxolol—glaucoma	0.000811	0.000894	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Clonidine—glaucoma	0.000811	0.000894	CcSEcCtD
Fosaprepitant—Pain—Dorzolamide—glaucoma	0.000808	0.000891	CcSEcCtD
Fosaprepitant—Insomnia—Pilocarpine—glaucoma	0.000807	0.00089	CcSEcCtD
Fosaprepitant—Decreased appetite—Brinzolamide—glaucoma	0.000807	0.00089	CcSEcCtD
Fosaprepitant—Weight decreased—Timolol—glaucoma	0.000807	0.000889	CcSEcCtD
Fosaprepitant—Constipation—Travoprost—glaucoma	0.000804	0.000887	CcSEcCtD
Fosaprepitant—Pain—Travoprost—glaucoma	0.000804	0.000887	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000802	0.000884	CcSEcCtD
Fosaprepitant—Asthenia—Bimatoprost—glaucoma	0.000802	0.000884	CcSEcCtD
Fosaprepitant—Fatigue—Brinzolamide—glaucoma	0.000801	0.000883	CcSEcCtD
Fosaprepitant—TACR1—Spinal Cord Injury—TNF—glaucoma	0.0008	0.00861	CbGpPWpGaD
Fosaprepitant—Angioedema—Clonidine—glaucoma	0.000798	0.00088	CcSEcCtD
Fosaprepitant—Dyspnoea—Pilocarpine—glaucoma	0.000796	0.000877	CcSEcCtD
Fosaprepitant—Pain—Brinzolamide—glaucoma	0.000794	0.000876	CcSEcCtD
Fosaprepitant—Somnolence—Pilocarpine—glaucoma	0.000794	0.000875	CcSEcCtD
Fosaprepitant—Angiopathy—Betaxolol—glaucoma	0.000793	0.000874	CcSEcCtD
Fosaprepitant—Pruritus—Bimatoprost—glaucoma	0.00079	0.000871	CcSEcCtD
Fosaprepitant—Immune system disorder—Betaxolol—glaucoma	0.000789	0.00087	CcSEcCtD
Fosaprepitant—Diarrhoea—Apraclonidine—glaucoma	0.000788	0.000869	CcSEcCtD
Fosaprepitant—Malaise—Clonidine—glaucoma	0.000788	0.000868	CcSEcCtD
Fosaprepitant—Mediastinal disorder—Betaxolol—glaucoma	0.000787	0.000868	CcSEcCtD
Fosaprepitant—Dyspepsia—Pilocarpine—glaucoma	0.000786	0.000866	CcSEcCtD
Fosaprepitant—Syncope—Clonidine—glaucoma	0.000783	0.000864	CcSEcCtD
Fosaprepitant—Feeling abnormal—Dorzolamide—glaucoma	0.000779	0.000858	CcSEcCtD
Fosaprepitant—Decreased appetite—Pilocarpine—glaucoma	0.000776	0.000856	CcSEcCtD
Fosaprepitant—Feeling abnormal—Travoprost—glaucoma	0.000775	0.000855	CcSEcCtD
Fosaprepitant—Conjunctivitis—Timolol—glaucoma	0.000773	0.000852	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Dorzolamide—glaucoma	0.000773	0.000852	CcSEcCtD
Fosaprepitant—Palpitations—Clonidine—glaucoma	0.000772	0.000851	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000771	0.00085	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Travoprost—glaucoma	0.000769	0.000848	CcSEcCtD
Fosaprepitant—Loss of consciousness—Clonidine—glaucoma	0.000768	0.000846	CcSEcCtD
Fosaprepitant—Feeling abnormal—Brinzolamide—glaucoma	0.000765	0.000844	CcSEcCtD
Fosaprepitant—Mental disorder—Betaxolol—glaucoma	0.000765	0.000844	CcSEcCtD
Fosaprepitant—Constipation—Pilocarpine—glaucoma	0.000763	0.000842	CcSEcCtD
Fosaprepitant—Pain—Pilocarpine—glaucoma	0.000763	0.000842	CcSEcCtD
Fosaprepitant—Cough—Clonidine—glaucoma	0.000762	0.00084	CcSEcCtD
Fosaprepitant—Dizziness—Apraclonidine—glaucoma	0.000762	0.00084	CcSEcCtD
Fosaprepitant—Erythema—Betaxolol—glaucoma	0.000761	0.000838	CcSEcCtD
Fosaprepitant—Malnutrition—Betaxolol—glaucoma	0.000761	0.000838	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—OPN4—glaucoma	0.000752	0.00809	CbGpPWpGaD
Fosaprepitant—Urticaria—Dorzolamide—glaucoma	0.000751	0.000827	CcSEcCtD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.000747	0.00804	CbGpPWpGaD
Fosaprepitant—Abdominal pain—Dorzolamide—glaucoma	0.000747	0.000823	CcSEcCtD
Fosaprepitant—Body temperature increased—Dorzolamide—glaucoma	0.000747	0.000823	CcSEcCtD
Fosaprepitant—Dysgeusia—Betaxolol—glaucoma	0.000745	0.000821	CcSEcCtD
Fosaprepitant—Chest pain—Clonidine—glaucoma	0.000744	0.00082	CcSEcCtD
Fosaprepitant—Abdominal pain—Travoprost—glaucoma	0.000744	0.00082	CcSEcCtD
Fosaprepitant—TACR1—GPCR ligand binding—EDN1—glaucoma	0.000742	0.00799	CbGpPWpGaD
Fosaprepitant—Anxiety—Clonidine—glaucoma	0.000741	0.000817	CcSEcCtD
Fosaprepitant—Asthenia—Acetazolamide—glaucoma	0.00074	0.000815	CcSEcCtD
Fosaprepitant—Dizziness—Bimatoprost—glaucoma	0.000739	0.000814	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000739	0.000814	CcSEcCtD
Fosaprepitant—Urticaria—Brinzolamide—glaucoma	0.000738	0.000813	CcSEcCtD
Fosaprepitant—Feeling abnormal—Pilocarpine—glaucoma	0.000736	0.000811	CcSEcCtD
Fosaprepitant—Discomfort—Clonidine—glaucoma	0.000735	0.00081	CcSEcCtD
Fosaprepitant—Vomiting—Apraclonidine—glaucoma	0.000733	0.000808	CcSEcCtD
Fosaprepitant—Muscle spasms—Betaxolol—glaucoma	0.000731	0.000806	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Pilocarpine—glaucoma	0.00073	0.000805	CcSEcCtD
Fosaprepitant—Hypersensitivity—Brimonidine—glaucoma	0.000729	0.000804	CcSEcCtD
Fosaprepitant—Dry mouth—Clonidine—glaucoma	0.000727	0.000802	CcSEcCtD
Fosaprepitant—Bradycardia—Timolol—glaucoma	0.000727	0.000801	CcSEcCtD
Fosaprepitant—Dermatitis—Apraclonidine—glaucoma	0.000726	0.0008	CcSEcCtD
Fosaprepitant—Headache—Apraclonidine—glaucoma	0.000722	0.000796	CcSEcCtD
Fosaprepitant—Oedema—Clonidine—glaucoma	0.000713	0.000786	CcSEcCtD
Fosaprepitant—Asthenia—Brimonidine—glaucoma	0.00071	0.000783	CcSEcCtD
Fosaprepitant—Infection—Clonidine—glaucoma	0.000708	0.000781	CcSEcCtD
Fosaprepitant—Abdominal pain—Pilocarpine—glaucoma	0.000706	0.000778	CcSEcCtD
Fosaprepitant—Body temperature increased—Pilocarpine—glaucoma	0.000706	0.000778	CcSEcCtD
Fosaprepitant—Ill-defined disorder—Betaxolol—glaucoma	0.000706	0.000778	CcSEcCtD
Fosaprepitant—TACR1—Spinal Cord Injury—TP53—glaucoma	0.000706	0.00759	CbGpPWpGaD
Fosaprepitant—Diarrhoea—Acetazolamide—glaucoma	0.000705	0.000777	CcSEcCtD
Fosaprepitant—Rash—Bimatoprost—glaucoma	0.000704	0.000777	CcSEcCtD
Fosaprepitant—Dermatitis—Bimatoprost—glaucoma	0.000704	0.000776	CcSEcCtD
Fosaprepitant—Anaemia—Betaxolol—glaucoma	0.000703	0.000775	CcSEcCtD
Fosaprepitant—Shock—Clonidine—glaucoma	0.000701	0.000773	CcSEcCtD
Fosaprepitant—Connective tissue disorder—Timolol—glaucoma	0.000701	0.000773	CcSEcCtD
Fosaprepitant—Pruritus—Brimonidine—glaucoma	0.0007	0.000772	CcSEcCtD
Fosaprepitant—Headache—Bimatoprost—glaucoma	0.0007	0.000772	CcSEcCtD
Fosaprepitant—Nervous system disorder—Clonidine—glaucoma	0.000699	0.000771	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—HEYL—glaucoma	0.000699	0.00752	CbGpPWpGaD
Fosaprepitant—Hypersensitivity—Dorzolamide—glaucoma	0.000696	0.000767	CcSEcCtD
Fosaprepitant—Hypersensitivity—Travoprost—glaucoma	0.000693	0.000764	CcSEcCtD
Fosaprepitant—Skin disorder—Clonidine—glaucoma	0.000692	0.000763	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Clonidine—glaucoma	0.000689	0.00076	CcSEcCtD
Fosaprepitant—Malaise—Betaxolol—glaucoma	0.000686	0.000756	CcSEcCtD
Fosaprepitant—Nausea—Apraclonidine—glaucoma	0.000684	0.000755	CcSEcCtD
Fosaprepitant—Hypersensitivity—Brinzolamide—glaucoma	0.000684	0.000754	CcSEcCtD
Fosaprepitant—Syncope—Betaxolol—glaucoma	0.000682	0.000752	CcSEcCtD
Fosaprepitant—Dizziness—Acetazolamide—glaucoma	0.000682	0.000751	CcSEcCtD
Fosaprepitant—Asthenia—Dorzolamide—glaucoma	0.000678	0.000747	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—PTGFR—glaucoma	0.000677	0.00729	CbGpPWpGaD
Fosaprepitant—Asthenia—Travoprost—glaucoma	0.000675	0.000744	CcSEcCtD
Fosaprepitant—Palpitations—Betaxolol—glaucoma	0.000672	0.000741	CcSEcCtD
Fosaprepitant—Pruritus—Dorzolamide—glaucoma	0.000668	0.000737	CcSEcCtD
Fosaprepitant—Loss of consciousness—Betaxolol—glaucoma	0.000668	0.000737	CcSEcCtD
Fosaprepitant—Eye disorder—Timolol—glaucoma	0.000667	0.000735	CcSEcCtD
Fosaprepitant—Asthenia—Brinzolamide—glaucoma	0.000666	0.000735	CcSEcCtD
Fosaprepitant—Hypotension—Clonidine—glaucoma	0.000666	0.000734	CcSEcCtD
Fosaprepitant—Pruritus—Travoprost—glaucoma	0.000666	0.000734	CcSEcCtD
Fosaprepitant—Tinnitus—Timolol—glaucoma	0.000665	0.000734	CcSEcCtD
Fosaprepitant—Cough—Betaxolol—glaucoma	0.000664	0.000732	CcSEcCtD
Fosaprepitant—Nausea—Bimatoprost—glaucoma	0.000664	0.000732	CcSEcCtD
Fosaprepitant—Cardiac disorder—Timolol—glaucoma	0.000662	0.00073	CcSEcCtD
Fosaprepitant—Hypersensitivity—Pilocarpine—glaucoma	0.000658	0.000725	CcSEcCtD
Fosaprepitant—Pruritus—Brinzolamide—glaucoma	0.000657	0.000724	CcSEcCtD
Fosaprepitant—Vomiting—Acetazolamide—glaucoma	0.000655	0.000723	CcSEcCtD
Fosaprepitant—Dizziness—Brimonidine—glaucoma	0.000654	0.000721	CcSEcCtD
Fosaprepitant—TACR1—GPCR ligand binding—C3—glaucoma	0.000648	0.00698	CbGpPWpGaD
Fosaprepitant—Angiopathy—Timolol—glaucoma	0.000648	0.000714	CcSEcCtD
Fosaprepitant—Chest pain—Betaxolol—glaucoma	0.000647	0.000714	CcSEcCtD
Fosaprepitant—Diarrhoea—Dorzolamide—glaucoma	0.000646	0.000713	CcSEcCtD
Fosaprepitant—Headache—Acetazolamide—glaucoma	0.000646	0.000712	CcSEcCtD
Fosaprepitant—Anxiety—Betaxolol—glaucoma	0.000645	0.000711	CcSEcCtD
Fosaprepitant—Insomnia—Clonidine—glaucoma	0.000645	0.000711	CcSEcCtD
Fosaprepitant—Immune system disorder—Timolol—glaucoma	0.000645	0.000711	CcSEcCtD
Fosaprepitant—Diarrhoea—Travoprost—glaucoma	0.000644	0.00071	CcSEcCtD
Fosaprepitant—Mediastinal disorder—Timolol—glaucoma	0.000643	0.000709	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000643	0.000709	CcSEcCtD
Fosaprepitant—Asthenia—Pilocarpine—glaucoma	0.000641	0.000706	CcSEcCtD
Fosaprepitant—TACR1—SIDS Susceptibility Pathways—TNF—glaucoma	0.00064	0.00689	CbGpPWpGaD
Fosaprepitant—Discomfort—Betaxolol—glaucoma	0.00064	0.000705	CcSEcCtD
Fosaprepitant—Dyspnoea—Clonidine—glaucoma	0.000636	0.000701	CcSEcCtD
Fosaprepitant—Diarrhoea—Brinzolamide—glaucoma	0.000636	0.000701	CcSEcCtD
Fosaprepitant—Somnolence—Clonidine—glaucoma	0.000634	0.000699	CcSEcCtD
Fosaprepitant—Dry mouth—Betaxolol—glaucoma	0.000633	0.000698	CcSEcCtD
Fosaprepitant—Pruritus—Pilocarpine—glaucoma	0.000632	0.000696	CcSEcCtD
Fosaprepitant—Mental disorder—Timolol—glaucoma	0.000625	0.000689	CcSEcCtD
Fosaprepitant—Dizziness—Dorzolamide—glaucoma	0.000625	0.000689	CcSEcCtD
Fosaprepitant—Rash—Brimonidine—glaucoma	0.000624	0.000688	CcSEcCtD
Fosaprepitant—Dermatitis—Brimonidine—glaucoma	0.000623	0.000687	CcSEcCtD
Fosaprepitant—Dizziness—Travoprost—glaucoma	0.000622	0.000686	CcSEcCtD
Fosaprepitant—Malnutrition—Timolol—glaucoma	0.000621	0.000685	CcSEcCtD
Fosaprepitant—Erythema—Timolol—glaucoma	0.000621	0.000685	CcSEcCtD
Fosaprepitant—Oedema—Betaxolol—glaucoma	0.000621	0.000684	CcSEcCtD
Fosaprepitant—Headache—Brimonidine—glaucoma	0.00062	0.000683	CcSEcCtD
Fosaprepitant—Decreased appetite—Clonidine—glaucoma	0.00062	0.000683	CcSEcCtD
Fosaprepitant—Infection—Betaxolol—glaucoma	0.000617	0.00068	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Clonidine—glaucoma	0.000615	0.000679	CcSEcCtD
Fosaprepitant—Fatigue—Clonidine—glaucoma	0.000615	0.000678	CcSEcCtD
Fosaprepitant—Dizziness—Brinzolamide—glaucoma	0.000614	0.000677	CcSEcCtD
Fosaprepitant—Nausea—Acetazolamide—glaucoma	0.000612	0.000675	CcSEcCtD
Fosaprepitant—Diarrhoea—Pilocarpine—glaucoma	0.000611	0.000673	CcSEcCtD
Fosaprepitant—Shock—Betaxolol—glaucoma	0.000611	0.000673	CcSEcCtD
Fosaprepitant—Pain—Clonidine—glaucoma	0.00061	0.000672	CcSEcCtD
Fosaprepitant—Constipation—Clonidine—glaucoma	0.00061	0.000672	CcSEcCtD
Fosaprepitant—Nervous system disorder—Betaxolol—glaucoma	0.000609	0.000671	CcSEcCtD
Fosaprepitant—Dysgeusia—Timolol—glaucoma	0.000608	0.000671	CcSEcCtD
Fosaprepitant—Skin disorder—Betaxolol—glaucoma	0.000603	0.000665	CcSEcCtD
Fosaprepitant—Vomiting—Dorzolamide—glaucoma	0.000601	0.000662	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Betaxolol—glaucoma	0.0006	0.000661	CcSEcCtD
Fosaprepitant—Rash—Dorzolamide—glaucoma	0.000596	0.000657	CcSEcCtD
Fosaprepitant—Dermatitis—Dorzolamide—glaucoma	0.000595	0.000656	CcSEcCtD
Fosaprepitant—Rash—Travoprost—glaucoma	0.000593	0.000654	CcSEcCtD
Fosaprepitant—Dermatitis—Travoprost—glaucoma	0.000593	0.000653	CcSEcCtD
Fosaprepitant—Headache—Dorzolamide—glaucoma	0.000592	0.000653	CcSEcCtD
Fosaprepitant—Vomiting—Brinzolamide—glaucoma	0.000591	0.000651	CcSEcCtD
Fosaprepitant—Dizziness—Pilocarpine—glaucoma	0.00059	0.000651	CcSEcCtD
Fosaprepitant—Headache—Travoprost—glaucoma	0.000589	0.00065	CcSEcCtD
Fosaprepitant—Nausea—Brimonidine—glaucoma	0.000588	0.000648	CcSEcCtD
Fosaprepitant—Feeling abnormal—Clonidine—glaucoma	0.000587	0.000648	CcSEcCtD
Fosaprepitant—Rash—Brinzolamide—glaucoma	0.000586	0.000646	CcSEcCtD
Fosaprepitant—Dermatitis—Brinzolamide—glaucoma	0.000585	0.000645	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Clonidine—glaucoma	0.000583	0.000643	CcSEcCtD
Fosaprepitant—Headache—Brinzolamide—glaucoma	0.000582	0.000641	CcSEcCtD
Fosaprepitant—Hypotension—Betaxolol—glaucoma	0.00058	0.000639	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—SMO—glaucoma	0.000578	0.00622	CbGpPWpGaD
Fosaprepitant—Angioedema—Timolol—glaucoma	0.000568	0.000626	CcSEcCtD
Fosaprepitant—Vomiting—Pilocarpine—glaucoma	0.000568	0.000626	CcSEcCtD
Fosaprepitant—Urticaria—Clonidine—glaucoma	0.000566	0.000624	CcSEcCtD
Fosaprepitant—Abdominal pain—Clonidine—glaucoma	0.000564	0.000621	CcSEcCtD
Fosaprepitant—Body temperature increased—Clonidine—glaucoma	0.000564	0.000621	CcSEcCtD
Fosaprepitant—Rash—Pilocarpine—glaucoma	0.000563	0.000621	CcSEcCtD
Fosaprepitant—Dermatitis—Pilocarpine—glaucoma	0.000562	0.00062	CcSEcCtD
Fosaprepitant—Insomnia—Betaxolol—glaucoma	0.000561	0.000619	CcSEcCtD
Fosaprepitant—Nausea—Dorzolamide—glaucoma	0.000561	0.000619	CcSEcCtD
Fosaprepitant—Headache—Pilocarpine—glaucoma	0.000559	0.000617	CcSEcCtD
Fosaprepitant—Nausea—Travoprost—glaucoma	0.000559	0.000616	CcSEcCtD
Fosaprepitant—Syncope—Timolol—glaucoma	0.000557	0.000614	CcSEcCtD
Fosaprepitant—Dyspnoea—Betaxolol—glaucoma	0.000553	0.00061	CcSEcCtD
Fosaprepitant—Nausea—Brinzolamide—glaucoma	0.000552	0.000608	CcSEcCtD
Fosaprepitant—Palpitations—Timolol—glaucoma	0.000549	0.000605	CcSEcCtD
Fosaprepitant—Dyspepsia—Betaxolol—glaucoma	0.000546	0.000602	CcSEcCtD
Fosaprepitant—Loss of consciousness—Timolol—glaucoma	0.000546	0.000602	CcSEcCtD
Fosaprepitant—Cough—Timolol—glaucoma	0.000542	0.000598	CcSEcCtD
Fosaprepitant—Decreased appetite—Betaxolol—glaucoma	0.00054	0.000595	CcSEcCtD
Fosaprepitant—Hypertension—Timolol—glaucoma	0.000536	0.000591	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Betaxolol—glaucoma	0.000536	0.000591	CcSEcCtD
Fosaprepitant—Fatigue—Betaxolol—glaucoma	0.000535	0.00059	CcSEcCtD
Fosaprepitant—Constipation—Betaxolol—glaucoma	0.000531	0.000585	CcSEcCtD
Fosaprepitant—Pain—Betaxolol—glaucoma	0.000531	0.000585	CcSEcCtD
Fosaprepitant—Nausea—Pilocarpine—glaucoma	0.00053	0.000585	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—RPTOR—glaucoma	0.00053	0.0057	CbGpPWpGaD
Fosaprepitant—Chest pain—Timolol—glaucoma	0.000529	0.000583	CcSEcCtD
Fosaprepitant—Anxiety—Timolol—glaucoma	0.000527	0.000581	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000525	0.000579	CcSEcCtD
Fosaprepitant—Hypersensitivity—Clonidine—glaucoma	0.000525	0.000579	CcSEcCtD
Fosaprepitant—Discomfort—Timolol—glaucoma	0.000523	0.000576	CcSEcCtD
Fosaprepitant—Dry mouth—Timolol—glaucoma	0.000517	0.00057	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—NCK2—glaucoma	0.000513	0.00552	CbGpPWpGaD
Fosaprepitant—Asthenia—Clonidine—glaucoma	0.000512	0.000564	CcSEcCtD
Fosaprepitant—Feeling abnormal—Betaxolol—glaucoma	0.000511	0.000564	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Timolol—glaucoma	0.000507	0.000559	CcSEcCtD
Fosaprepitant—Oedema—Timolol—glaucoma	0.000507	0.000559	CcSEcCtD
Fosaprepitant—Pruritus—Clonidine—glaucoma	0.000504	0.000556	CcSEcCtD
Fosaprepitant—Infection—Timolol—glaucoma	0.000504	0.000555	CcSEcCtD
Fosaprepitant—Shock—Timolol—glaucoma	0.000499	0.00055	CcSEcCtD
Fosaprepitant—Nervous system disorder—Timolol—glaucoma	0.000497	0.000548	CcSEcCtD
Fosaprepitant—Urticaria—Betaxolol—glaucoma	0.000493	0.000544	CcSEcCtD
Fosaprepitant—Skin disorder—Timolol—glaucoma	0.000493	0.000543	CcSEcCtD
Fosaprepitant—Body temperature increased—Betaxolol—glaucoma	0.000491	0.000541	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Timolol—glaucoma	0.00049	0.00054	CcSEcCtD
Fosaprepitant—Diarrhoea—Clonidine—glaucoma	0.000488	0.000538	CcSEcCtD
Fosaprepitant—Hypotension—Timolol—glaucoma	0.000474	0.000522	CcSEcCtD
Fosaprepitant—Dizziness—Clonidine—glaucoma	0.000471	0.00052	CcSEcCtD
Fosaprepitant—Insomnia—Timolol—glaucoma	0.000459	0.000506	CcSEcCtD
Fosaprepitant—Hypersensitivity—Betaxolol—glaucoma	0.000457	0.000504	CcSEcCtD
Fosaprepitant—Vomiting—Clonidine—glaucoma	0.000453	0.0005	CcSEcCtD
Fosaprepitant—Dyspnoea—Timolol—glaucoma	0.000452	0.000498	CcSEcCtD
Fosaprepitant—Somnolence—Timolol—glaucoma	0.000451	0.000497	CcSEcCtD
Fosaprepitant—Rash—Clonidine—glaucoma	0.00045	0.000496	CcSEcCtD
Fosaprepitant—Dermatitis—Clonidine—glaucoma	0.000449	0.000495	CcSEcCtD
Fosaprepitant—Headache—Clonidine—glaucoma	0.000447	0.000492	CcSEcCtD
Fosaprepitant—Dyspepsia—Timolol—glaucoma	0.000446	0.000492	CcSEcCtD
Fosaprepitant—Asthenia—Betaxolol—glaucoma	0.000445	0.000491	CcSEcCtD
Fosaprepitant—Decreased appetite—Timolol—glaucoma	0.000441	0.000486	CcSEcCtD
Fosaprepitant—Pruritus—Betaxolol—glaucoma	0.000439	0.000484	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Timolol—glaucoma	0.000438	0.000483	CcSEcCtD
Fosaprepitant—Fatigue—Timolol—glaucoma	0.000437	0.000482	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—HDAC9—glaucoma	0.000436	0.00469	CbGpPWpGaD
Fosaprepitant—Pain—Timolol—glaucoma	0.000434	0.000478	CcSEcCtD
Fosaprepitant—Diarrhoea—Betaxolol—glaucoma	0.000425	0.000468	CcSEcCtD
Fosaprepitant—Nausea—Clonidine—glaucoma	0.000423	0.000467	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—EDN1—glaucoma	0.00042	0.00452	CbGpPWpGaD
Fosaprepitant—Feeling abnormal—Timolol—glaucoma	0.000418	0.000461	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Timolol—glaucoma	0.000415	0.000457	CcSEcCtD
Fosaprepitant—Dizziness—Betaxolol—glaucoma	0.00041	0.000452	CcSEcCtD
Fosaprepitant—Urticaria—Timolol—glaucoma	0.000403	0.000444	CcSEcCtD
Fosaprepitant—Abdominal pain—Timolol—glaucoma	0.000401	0.000442	CcSEcCtD
Fosaprepitant—Body temperature increased—Timolol—glaucoma	0.000401	0.000442	CcSEcCtD
Fosaprepitant—Vomiting—Betaxolol—glaucoma	0.000395	0.000435	CcSEcCtD
Fosaprepitant—Rash—Betaxolol—glaucoma	0.000391	0.000431	CcSEcCtD
Fosaprepitant—Dermatitis—Betaxolol—glaucoma	0.000391	0.000431	CcSEcCtD
Fosaprepitant—Headache—Betaxolol—glaucoma	0.000389	0.000429	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—EDN1—glaucoma	0.000381	0.0041	CbGpPWpGaD
Fosaprepitant—Hypersensitivity—Timolol—glaucoma	0.000374	0.000412	CcSEcCtD
Fosaprepitant—Nausea—Betaxolol—glaucoma	0.000369	0.000406	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—C3—glaucoma	0.000366	0.00394	CbGpPWpGaD
Fosaprepitant—Asthenia—Timolol—glaucoma	0.000364	0.000401	CcSEcCtD
Fosaprepitant—Pruritus—Timolol—glaucoma	0.000359	0.000395	CcSEcCtD
Fosaprepitant—Diarrhoea—Timolol—glaucoma	0.000347	0.000382	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—SMO—glaucoma	0.000341	0.00367	CbGpPWpGaD
Fosaprepitant—Dizziness—Timolol—glaucoma	0.000335	0.00037	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—C3—glaucoma	0.000333	0.00358	CbGpPWpGaD
Fosaprepitant—Vomiting—Timolol—glaucoma	0.000322	0.000355	CcSEcCtD
Fosaprepitant—Rash—Timolol—glaucoma	0.00032	0.000352	CcSEcCtD
Fosaprepitant—Dermatitis—Timolol—glaucoma	0.000319	0.000352	CcSEcCtD
Fosaprepitant—Headache—Timolol—glaucoma	0.000318	0.00035	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—NTRK2—glaucoma	0.000312	0.00336	CbGpPWpGaD
Fosaprepitant—Nausea—Timolol—glaucoma	0.000301	0.000332	CcSEcCtD
Fosaprepitant—TACR1—Signaling Pathways—NGFR—glaucoma	0.000268	0.00288	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—NTRK1—glaucoma	0.000254	0.00274	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CDKN2B—glaucoma	0.000235	0.00252	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—EDN1—glaucoma	0.000225	0.00242	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—NGF—glaucoma	0.000207	0.00223	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—C3—glaucoma	0.000197	0.00212	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—APOE—glaucoma	0.000183	0.00197	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CAV1—glaucoma	0.000181	0.00195	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—FN1—glaucoma	0.000173	0.00186	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—BAD—glaucoma	0.000171	0.00184	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—NOS3—glaucoma	0.000137	0.00148	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—CDKN1B—glaucoma	0.000119	0.00128	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—MMP9—glaucoma	0.00011	0.00118	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—VEGFA—glaucoma	9.88e-05	0.00106	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—TP53—glaucoma	7.46e-05	0.000803	CbGpPWpGaD
